The proposed bill aims to limit co-payments for prescription drugs and related medical supplies prescribed for chronic diseases in Minnesota. It introduces a new section, [62Q.481] COST-SHARING FOR PRESCRIPTION DRUGS AND RELATED MEDICAL SUPPLIES TO TREAT CHRONIC DISEASE, which mandates that health plans cap enrollee cost-sharing at $25 for a one-month supply of each prescription drug and $50 per month for all related medical supplies, regardless of the number of chronic diseases treated. The bill specifies that these costs will not be subject to any deductible and outlines definitions for "chronic disease," "cost-sharing," and "related medical supplies." The effective date for these provisions is set for January 1, 2024. Additionally, the bill amends existing statutes, specifically Minnesota Statutes 2022, sections 256B.0631 and 256L.03, to incorporate the new cost-sharing requirements for chronic disease treatments. It includes a new clause in section 256B.0631, subdivision 1, stating that cost-sharing for prescription drugs and related medical supplies must comply with the new section 62Q.481. Similarly, section 256L.03, subdivision 5, is amended to reflect the same compliance requirement. The effective date for these amendments is also January 1, 2024.

Statutes affected:
1st Engrossment: 256B.0631, 256L.03
1st Engrossment: 256B.0631, 256L.03